301.
Effects of Morin on an Experimental Model of Acute Colitis in Rats
by Ocete, M. Angeles
Pharmacology, 1998-11, Vol.57 (5), p.261-270
302.
The Protection of the Retina from Ischemic Injury by the Free Radical Scavenger EGb 761 and Zinc in the Cat Retina
by Kim, Si-Yeol
Ophthalmologica (Basel), 1998-08, Vol.212 (4), p.268-274
303.
Anti-inflammatory activity of myricetin-3-O-beta-D-glucuronide and related compounds
by Hiermann, A
Inflammation research, 1998-11, Vol.47 (11), p.421-427
304.
Effects of Micronised Purified Flavonoid Fraction on Pain, Spermiogram and Scrotal Color Doppler Parameters in Patients with Painful Varicocele
by Kiliç, Süleyman
Urologia internationalis, 2005-03, Vol.74 (2), p.173-179
305.
Chemoprevention of superficial bladder cancer
by Kamat, Ashish M
Expert review of anticancer therapy, 2003-12-01, Vol.3 (6), p.799-808
306.
Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids
by Khubchandani, I T
Techniques in coloproctology, 2001-04, Vol.5 (1), p.57-58
307.
Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids
by Ferrándiz, M. L.
Agents and Actions, 1991-03, Vol.32 (3-4), p.283-288
308.
Chemoprevention of cancer for the next millennium — quo vadis?
by Zänker, Kurt S
Cancer letters, 1999, Vol.143, p.S7-S11
309.
Dietary bioflavonoids, chalcones, and related alkenones in prevention and treatment of cancer
by Varma, Rajender S
Nutrition (Burbank, Los Angeles County, Calif.), 1996, Vol.12 (9), p.643-645
310.
Flavonoid-mediated tumor growth suppression demonstrated by in vivo study
by KAMEI, H
Cancer biotherapy & radiopharmaceuticals, 1996, Vol.11 (3), p.193-196
311.
Nutriceuticals for cardiovascular health
by Cooke, John P
The American journal of cardiology, 1998, Vol.82 (10), p.S43-S46
312.
Pycnogenol for diabetic retinopathy. A review
by Schönlau, F
International ophthalmology, 2001, Vol.24 (3), p.161-171
313.
Hepatoprotective Effect of Morin on Ethanol-Induced Hepatotoxicity in Rats
by Shankari, S.G.
Journal of basic and clinical physiology and pharmacology, 2010, Vol.21 (4), p.277-294
314.
Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours
by CUMMINGS, J
Cancer chemotherapy and pharmacology, 1989, Vol.24 (5), p.269-272
315.
Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia
by TAKEUCHI, H
Cancer chemotherapy and pharmacology, 1996, Vol.38 (1), p.1-8
316.
Activity of flavone acetic acid (NSC-347512) against solid tumors of mice
by Corbett, T H
Investigational new drugs, 1986, Vol.4 (3), p.207
317.
Cancer Chemoprevention and Apoptosis Mechanisms Induced by Dietary Polyphenolics
by Galati, G.
Drug metabolism and drug interactions, 2000, Vol.17 (1-4), p.311-350
318.
Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinization
by DE FORNI, M
Cancer chemotherapy and pharmacology, 1995, Vol.35 (3), p.219-224
319.
Nitric oxide : its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid
by THOMSEN, L. L
Cancer chemotherapy and pharmacology, 1992, Vol.31 (2), p.151-155
320.
Flavone acetic acid (LM 975, NSC 347512): a novel antitumor agent
by O'DWYER, P. J
Cancer chemotherapy and pharmacology, 1987, Vol.19 (1), p.6-10
